MDASI-HN Scores Predict Hypoglossal Neuropathy Risk in Oropharyngeal Cancer

Late radiation-associated dysphagia remains a persistent burden for oropharyngeal cancer survivors, with symptoms often peaking within three months but continuing to affect patients for years post-treatment [1]. Recent evidence suggests that hypoglossal neuropathy (damage to the twelfth cranial nerve which controls tongue movement) is a near-universal finding in patients with fibrosis-related swallowing dysfunction, with subclinical nerve damage often detectable via electromyography before overt clinical signs emerge [2]. Despite the significant symptom burden and quality-of-life impact associated with lower cranial neuropathies, there is currently no clinical consensus or standardized guidelines for the long-term assessment of these latent toxicities [3, 4]. Risk factors such as high cumulative radiation doses and continued tobacco use further increase the likelihood of developing chronic speech and voice impairments in this population [5]. A new study now evaluates whether specific patient-reported symptoms can serve as an early warning system for impending nerve failure.